The weekly litigation news digest is live. Subscribe now

IP Verse

Anti-Il1Rap Antibodies And Their Use For Treating Human - EP3020730

The patent EP3020730 was granted to Cantargia on Dec 26, 2018. The application was filed on Jan 19, 2012 under application number EP15197139A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP3020730

CANTARGIA
Application Number
EP15197139A
Filing Date
Jan 19, 2012
Status
Opposition Rejected
May 24, 2024
Publication Date
Dec 26, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
MAB DISCOVERYSep 25, 2019ZWICKERWITHDRAWN

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0213303
DESCRIPTIONUS4235871
DESCRIPTIONUS4816567
DESCRIPTIONUS5851451
OPPOSITIONEP2665749
OPPOSITIONUS2006019256
OPPOSITIONWO2012098407
SEARCHWO9623067

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents